CoChat

Matriptase-2 deficiency protects from obesity by modulating iron homeostasis

Open access
Folgueras, Alicia R., Freitas-Rodríguez, Sandra, Ramsay, Andrew J., Garabaya, Cecilia, Rodríguez, Francisco, Velasco, Gloria, López-Otín, Carlos · 2018 · Nature Communications
Cited by 49

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Alterations in iron status have frequently been associated with obesity and other metabolic disorders. The hormone hepcidin stands out as a key regulator in the maintenance of iron homeostasis by controlling the main iron exporter, ferroportin. Here we demonstrate that the deficiency in the hepcidin repressor matriptase-2 (Tmprss6) protects from high-fat diet-induced obesity. Tmprss6 −/− mice show a significant decrease in body fat, improved glucose tolerance and insulin sensitivity, and are protected against hepatic steatosis. Moreover, these mice exhibit a significant increase in fat lipolysis, consistent with their dramatic reduction in adiposity. Rescue experiments that block hepcidin up-regulation and restore iron levels in Tmprss6−/− mice via anti-hemojuvelin (HJV) therapy, revert the obesity-resistant phenotype of Tmprss6−/− mice. Overall, this study describes a role for matritpase-2 and hepcidin in obesity and highlights the relevance of iron regulation in the control of adipose tissue function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-03853-1

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 31

  1. Theurl, I. et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113, 5277–5286 (2009). · DOI · Paper page
  2. Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093 (2004). · DOI · Paper page
  3. Dongiovanni, P. et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am. J. Pathol. 182, 2254–2263 (2013). · DOI · Paper page
  4. Gabrielsen, J. S. et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Invest 122, 3529–3540 (2012). · DOI · Paper page
  5. Gao, Y. et al. Adipocyte iron regulates leptin and food intake. J. Clin. Invest 125, 3681–3691 (2015). · DOI · Paper page
  6. Folgueras, A. R. et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112, 2539–2545 (2008). · DOI · Paper page
  7. Willemetz, A. et al. Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis. Blood 124, 441–444 (2014). · DOI
  8. Ramsay, A. J., Hooper, J. D., Folgueras, A. R., Velasco, G. & Lopez-Otin, C. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 94, 840–849 (2009). · DOI
  9. Wang, C. Y., Meynard, D. & Lin, H. Y. The role of TMPRSS6/matriptase-2 in iron regulation and anemia. Front Pharmacol. 5, 114 (2014).
  10. Lenoir, A. et al. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6. Blood 117, 647–650 (2011). · DOI · Paper page
  11. Ramsay, A. J. et al. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. Hum. Mol. Genet. 18, 3673–3683 (2009). · DOI · Paper page
  12. De Falco, L. et al. Iron refractory iron deficiency anemia. Haematologica 98, 845–853 (2013). · DOI · Paper page
  13. Heeney, M. M. & Finberg, K. E. Iron-refractory iron deficiency anemia (IRIDA). Hematol. Oncol. Clin. North Am. 28, 637–652 (2014). · DOI
  14. Daba, A., Gkouvatsos, K., Sebastiani, G. & Pantopoulos, K. Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing. J. Mol. Med. 91, 95–102 (2013). · DOI
  15. Matsusue, K. et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 7, 302–311 (2008). · DOI · Paper page
  16. Mottillo, E. P., Shen, X. J. & Granneman, J. G. Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue. Am. J. Physiol. Endocrinol. Metab. 293, E1188–E1197 (2007). · DOI · Paper page
  17. Kraemer, F. B. & Shen, W. J. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J. Lipid Res. 43, 1585–1594 (2002). · DOI · Paper page
  18. Martinelli, N. et al. Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. PLoS ONE 7, e48250 (2012). · DOI · Paper page
  19. Barisani, D. et al. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. J. Hepatol. 49, 123–133 (2008). · DOI
  20. Bridle, K. R. et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673 (2003). · DOI · Paper page
  21. Powell, E. E. et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 129, 1937–1943 (2005). · DOI · Paper page
  22. Bonkovsky, H. L. et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J. Hepatol. 31, 421–429 (1999). · DOI · Paper page
  23. Tan, T. C. et al. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G865–G876 (2011). · DOI
  24. Lu, S., Bennett, R. G., Kharbanda, K. K. & Harrison-Findik, D. D. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J. Hepatol. 8, 211–225 (2016). · DOI
  25. Finberg, K. E., Whittlesey, R. L., Fleming, M. D. & Andrews, N. C. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 115, 3817–3826 (2010). · DOI · Paper page
  26. Kovac, S. et al. Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels. Haematologica 101, e173–e176 (2016). · DOI · Paper page
  27. Cooksey, R. C. et al. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am. J. Physiol. Endocrinol. Metab. 298, E1236–E1243 (2010). · DOI · Paper page
  28. Patil, M. et al. Id1 Promotes obesity by suppressing brown adipose thermogenesis and white adipose browning. Diabetes 66, 1611–1625 (2017). · DOI
  29. Satyanarayana, A., Klarmann, K. D., Gavrilova, O. & Keller, J. R. Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis. FASEB J. 26, 309–323 (2012). · DOI
  30. Cutchins, A. et al. Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion. Arterioscler. Thromb. Vasc. Biol. 32, 317–324 (2012). · DOI
  31. Murad, J. M. et al. Inhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in mice. J. Biol. Chem. 285, 24164–24173 (2010). · DOI

Cited by

See all 49

Metadata

Authors
Folgueras, A. R., Freitas-Rodríguez, S., Ramsay, A. J., Garabaya, C., Rodríguez, F., Velasco, G., & López-Otín, C.
Venue
Nature Communications
Published
2018-04-10
Volume
9
Issue
1
Pages
1350-1350
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2797532322
Cited by
49
References
10
FWCI
2.43
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Matriptase-2 deficiency protects from obesity by modulating iron homeostasis. https://app.cochat.ai/papers/10.1038/s41467-018-03853-1
The paper
Folgueras, A. R., Freitas-Rodríguez, S., Ramsay, A. J., Garabaya, C., Rodríguez, F., Velasco, G., & López-Otín, C. (2018). Matriptase-2 deficiency protects from obesity by modulating iron homeostasis. Nature Communications. https://doi.org/10.1038/s41467-018-03853-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.